Country: Malta
Language: English
Source: Medicines Authority
CISPLATIN
Hospira UK Limited
L01AX01
CISPLATIN
CONCENTRATE FOR SOLUTION FOR INFUSION
CISPLATIN 1 mg/ml
POM
ANTINEOPLASTIC AGENTS
Authorised
2006-12-28
Page 1 of 8 2016-0018324 PACKAGE LEAFLET: INFORMATION FOR THE USER CISPLATIN 1 MG/ML STERILE CONCENTRATE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. IN THIS LEAFLET: 1. What Cisplatin Sterile Concentrate is and what it is used for 2. Before you use Cisplatin Sterile Concentrate 3. How to use Cisplatin Sterile Concentrate 4. Possible side effects 5. How to store Cisplatin Sterile Concentrate 6. Further information 1. WHAT CISPLATIN STERILE CONCENTRATE IS AND WHAT IT IS USED FOR Cisplatin forms part of a group of medicines called cytostatics, which are used in the treatment of cancer. Cisplatin can be used alone but more commonly Cisplatin is used in combination with other cyostatics. WHAT IS IT USED FOR? Cisplatin can destroy cells in your body that may cause certain types of cancer (tumour of testis, tumour of ovary, tumour of the bladder, head and neck epithelial tumour, lung cancer and for cervical cancer in combination with radiotherapy). 2. BEFORE YOU USE CISPLATIN STERILE CONCENTRATE DO NOT USE CISPLATIN STERILE CONCENTRATE if you have shown signs of hypersensitivity (severe allergy) to cisplatin or similar anti-cancer medicines in the past if you have severe kidney disease if you have hearing difficulties if you have very low numbers of blood cells (called ‘myelosuppression’), (your doctor will check this with a blood test) if you are dehydrated if you are breast-feeding if you need to have a vaccine for ‘yellow fever’ Tell your doctor if the above applies to you before this medicine is used. TAKE SPECIAL CARE WITH CISPLATIN STERILE CONCENTRATE Page 2 of 8 2016-0018324 if you have any symptoms of nerve damage (peripheral neuropathy) such as pins and needles, numbness or poor sense of touc Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cisplatin 1 mg/ml Sterile Concentrate 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of concentrate for solution for infusion contains 1 mg of cisplatin. 1 vial of 10 ml concentrate for solution for infusion contains 10 mg of cisplatin. 1 vial of 50 ml concentrate for solution for infusion contains 50 mg of cisplatin. 1 vial of 100 ml concentrate for solution for infusion contains 100 mg of cisplatin. For excipients, see 6.1. 3. PHARMACEUTICAL FORM Concentrate for Solution for Infusion. Vials containing a clear, colourless to pale yellow solution. 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Cisplatin is intended for the treatment of: - Advanced or metastasised testicular cancer - Advanced or metastasised ovarian cancer - Advanced or metastasised bladder carcinoma - Advanced or metastasised squamous cell carcinoma of the head and neck - Advanced or metastasised non-small cell lung carcinoma - Advanced or metastasised small cell lung carcinoma Cisplatin is indicated in the treatment of cervical carcinoma in combination with other chemotherapeutics or with radiotherapy. Cisplatin can be used as monotherapy and in combination therapy. 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Cisplatin 1 mg/ml Sterile Concentrate is to be diluted before administration. For instructions for dilution of the product before administrate, see section 6.6. The diluted solution should be administered only intravenously by infusion (see below). For administration, any device containing aluminium that may come in contact with cisplatin (sets for intravenous infusion, needles, catheters, syringes) must be avoided. ADULTS AND CHILDREN The cisplatin dosage depends on the primary disease, the expected reaction, and on whether cisplatin is used for monotherapy or as a component of combination chemotherapy. The dosage directions are applicable for both adults and children. For monotherapy, the following two dosage regimens are recommended: << Single dose of 50 to 120 mg Read the complete document